SUMMARY
In vitro antigenic reactivity of chemically synthesized monosaccharide analogues of nonreducing sugar moiety of lipid A with 4 monoclonal antibodies against Salmonella minnesota R595 lipid A was studied by the inhibition test of enzyme-linked immunosorbent assay (ELISA). In the assays with 2 monoclonal antibodies (mAb 5G and mAb36G), which have been suggested to recognize the Salmonella type lipid A structure, no antigenic reactivity of the tested analogues was observed. However, several monosaccharide analogues exhibited antigenic reactivities with other monoclonal antibodies (mAbl61M and mAbl-9M), especially some structural differences of hydrophobic and/or hydrophilic parts among monosaccharide analogues were recognized by mAbl61M.
INTRODUCTION
Our previous studies [1] [2] [3] [4] on the lipid A epitopes of Gram-negative bacterial lipopolysaccharides suggested that the structure of the hydrophobic part as well as the hydrophilic backbone of lipid A play an important role in determining serological specificity of the lipid A molecule. In these studies, the in vitro antigenic reactivity Of a number of chemically synthesized lipid A analogues with free lipid A preparations from many species including E. coli, Salmonella minnesota and Pseudomonas diminuta was analyzed by the ELISA and ELISA inhibition test using monoclonal and conventional antibodies.
To obtain further information on the fine structural requirements of lipid A epitopes, we examined in vitro antigenic reactivity of chemically synthesized monosaccharide analogues related to the nonreducing sugar moiety of lipid A with monoclonal antibodies.
MATERIALS AND METHODS
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GLA-48*** C14-0-(C14) Cl4 P were synthesized according to procedures described elsewhere [5] [6] [7] [8] [9] . The free lipid A preparation from Salmonella minnesota R595 [1, 2] was used as a reference natural product. The antigenic reactivities of synthetic compounds were determined by ELISA inhibition test using antilipid A monoclonal antibodies [2] . Briefly, a fixed dilution of lipid A antibodies was preincubated for 30 min at 37 °C with an equal volume of inhibiting ligands in different concentrations. These mixtures (0.2 ml) were then placed in the wells of microtitration plates (Linbro/Titertek, Flow Laboratories, Inc., McLean, VA), which were precoated with the R595 lipid A, and incubated for 2.5 h at 37 o C. After washing, the standard ELISA procedure [2] was followed. The 50Fo inhibitory value was expressed as the #g/well of a ligand needed to obtain a 50% decrease in the optical density as compared with the control well to which no inhibitor was added. The monoclonal antibodies 5G (IgG 2b), 36G (IgG3), 161M (IgM) and 1-gM (IgM) have been described [2, 3] .
RESULTS AND DISCUSSION
As shown in Fig. 1 , tested compounds were classified into 4 groups based on their backbone structure (I-IV), in which the C-2 and C-3 positions of the 1-deoxy form of D-glucosamine (II), the allose form (III) and 2,3-diamino-2,3-dideoxy-D-glucose (IV) are substituted by the same acyl residues as with those of GLA-27, but compounds of D-glucosamine (I) have different fatty acyl substituents. The results of the ELISA inhibition test with these compounds are shown in Table 1 .
In the assay systems with mAb5G and mAb36G, which showed high affinities to the Salmonella type lipid A [2] , no antigenic reactivity was observed in any compounds including GLA-47, with a structure nearly equal to that of the nonreducing moiety of Salmonella type lipid A. In the previous study [2] , we observed that mAb5G and 36G did not cross-react with synthetic compounds of lipid X and lipid Y, which respectively correspond to the reducing moiety of E. coli type and Salmonella type lipid A. These results sup-233 port our previous suggestion [2] that the glucosamine disaccharide 1,4'-bisphosphate structure as well as the suitable acyl groups is essential to the recognition of lipid A by mAb5G or 36G.
On the other hand, we found that mAbl61M, which cross-reacts with lipid A from many species including P. diminuta [2, 3] , cross-reacted with synthetic monosaccharide analogues, though significant differences in their antigenic reactivities were observed. Namely compound GLA-27, which is 4-O-phosphoryl-D-glucosamine with 2-N-3-tetradecanoyloxytetradecanoyl and 3-O-tetradecanoyl groups, exhibited a distinct reactivity, though slightly weak compared with the strain R595 lipid A. In the same assay system, compound 47, which carries 2 acyloxyacyl groups, was also active, but compound-34(R3=H), GLA-44 (R2=C14-OH) and GLA-46(R 2, R3=CIn-OH) were inactive or hardly active compared to GLA-27. Among compounds with the similar acyl groups but different chain lengths from those of GLA-27, 3 analogues (GLA-38, 57 and 58) were active inhibitors, but GLA-37, having acyl groups of a Table 1 Antigenic reactivity of synthetic monosaccharide analogues as determined by ELISA inhibition test Microtitration plates were coated with S. minnesota R595 lipid A at a dose of 2 ~g/0.2 ml per well. The ELISA inhibition test with monoclonal antibodies 5G(IgG 2b), 36G(IgG 3), 161M(IgM) and 1-9M(IgM) against strain R595 lipid A was performed as described in Materials and Methods.
Compounds used as inhibitors
Amount (/* g) of inhibitor needed for 50% inhibition by the following monoclonal antibodies short chain length, was inactive. In addition, the antigenic reactivity of GLA-27-R, a diastereoisomer of GLA-27 appeared to be slightly stronger than that of another diastereoisomer GLA-27-S. These results show that the nature of acyl linkages, the chain length of fatty acid and the configuration of 3-hydroxy fatty acids might play an important role in the serological reactivity.
Since compounds GLA-40 and GLA-43 were considerably less active compared to GLA-27 despite their carrying the same acyl groups, and since compound GLA-48 containing 3-amino-o-glucosamine as the backbone was active, it was also considered that the backbone structure also participates in the antigenic reactivity. In connection with the activity of GLA-48, it is important to note that the P. diminuta lipid A, which cross-reacted with mAbl61M, contains monophosphorylated 3-amino-D-glucosamine disaccharide as the backbone [4] . It has been shown [2] that mAbl-9M is similar to mAb161M in that they strongly cross-react with the E. coli or Salmonella type monophosphoryl lipid A analogues as well as the usual diphosphoryl lipid A. In the present study, also mAbl-9M exhibited cross-reactivities with most compounds that were active in the assay with mAbl61M (Table 1). However, it should be noted that the mAbl-9M more strongly recognizes glucosamine disaccharide analogues than glucosamine monosaccharide analogues ( [2] and unpublished observations).
In conclusion, the present study supports our hypothesis that lipid A epitopes are constructed by the chemical structure and conformation of the backbone and hydrophobic parts of the lipid A molecule, and that the serological specificities are determined by the structure of the backbone and/or acyl residues [2] .
